Efficacy and safety of fruquintinib alone and in combination with PD-1 inhibitors for postline treatment of advanced metastatic colon cancer

HU Lang; LIN Xiaoling; TANG Wenjun

doi:10.3969/j.issn.1006-5725.2023.15.019

Home>Articles>Efficacy and safety of fruquintinib alone and in combination with PD-1 inhibitors for postline treatment of advanced metastatic colon cancer

DOI: 10.3969/j.issn.1006-5725.2023.15.019

Efficacy and safety of fruquintinib alone and in combination with PD-1 inhibitors for postline treatment of advanced metastatic colon cancer

HU Lang

LIN Xiaoling

TANG Wenjun

Keywords：advanced colorectal cancerfruquintinibPD-1 monoclonal antibodyefficacysafety

Publication Date：2023-08-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：8( 1966-1973 )

The Journal of Practical Medicine

ISTICPKU

ISSN：1006-5725

Year, Vol.(Issue)：2023,39(15)